Navigation Links
Australia awaits US FDA reports on ADHD drugs

United States has asked the US Food and Drug Administration to study the safety of the drugs used in the treatment of Attention Deficit Hyperactivity Disorder (ADHD) following reports that the drug usage // causes cardiovascular diseases such as strokes and heart attacks. The US committee would meet on starting of february to review the safety of ADHD drugs. The Therapeutic Goods Administration (TGA) in Australia is responsible for the safety of drugs and has said that the TGA // would take action after the US committee submits its review report and TGA feels that it is not going to start a separate enquiry to investigate the drug action but , had asked their countries physicians to report of any adverse effects reported by their patients taking this drug. Dexamphetamine sulphate is the mostly used ADHD drug and it is widely used in Australia.
'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australia earmarks $74 Million to Fight Bird Flu
3. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
4. Obesity among The Poor in Australia.
5. Increase In Health Insurance Premium Likely In Australia
6. Australian Company Gets $10 million For Developing Skin Cancer Gel
7. Australian Health funds stand accused
8. Bird flu scare in Australia
9. Australia to Show Leniency towards U.S. Pharmaceutical Companies
10. No booster vaccine For every fourth child in Australia
11. Australia Witnesses A Fall In the Number of Organ Donors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/24/2017)... ... April 24, 2017 , ... Labs often perform the ... for lab operators and management to assess these processes with a critical eye—particularly ... unnecessary actions. , Created with the help of both internal and external ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... clearly shows that over the last decade, student well-being has seriously declined. "When ... boxes of formal education, join the Islamic State to turn the historic multi-ethnic ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation ... former Chairman of the Board of Directors for CONTACT USA, and former member of ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... Gallardo, DDS, PA will be attending the 2017 Oral Reconstruction Foundation’s 2017 Symposium ... , The Oral Reconstruction Foundation will present its annual Global Symposium at the ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... brands, work wear distributors and International relief organizations across the globe to provide ... also offers lifestyle and work wear collections via insectshield.com . In the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  AbbVie (NYSE: ABBV), a global biopharmaceutical company, ... hepatitis C virus (HCV) infected patients with genotype ... cirrhosis (Child-Pugh A) achieved sustained virologic response at ... investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high ... weeks of G/P treatment without ribavirin. Patients with ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... YORK , April 19, 2017 Cardiology devices ... the projected period The Cardiology Devices segment is ... than US$ 15 Mn in 2018 over 2017. By the ... a market valuation close to US$ 700 Mn, expanding at ... Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: